Table 1 Clinical characteristics of 301 newly diagnosed multiple myeloma patients.
Characteristic | N = 301 |
|---|---|
Gender—no. (%) | |
Male | 156 (51.8) |
Female | 145 (48.2) |
Age, years—median [range] | 61 [29–80] |
Hemoglobin, g/L—median [range] | 94 [39–169] |
LDH, U/L- median [range] | 157.8 [67.1–523.0] |
Serum β2-microglobulin, mg/L—median [range] | 3.6 [1.0–78.1] |
ISS stage—no. (%) | |
I | 62 (21.3) |
II | 135 (46.4) |
III | 94 (32.3) |
Missing | 10 |
R-ISS stage—no. (%) | |
I | 43 (14.8) |
II | 194 (66.7) |
III | 54 (18.5) |
Missing | 10 |
Immunoglobulin isotype—no. (%) | |
IgG | 174 (58.2) |
IgA | 81 (27.1) |
IgD | 9 (3.0) |
IgM | 1 (0.3) |
Light-chain only—no. (%) | 31 (10.4) |
Non-secretory—no. (%) | 3 (1.0) |
Missing | 2 |
FISH—no. (%) | |
t (4; 14) | 78 (26.4) |
t (11; 14) | 45 (15.2) |
t (14; 16) | 6 (2.0) |
t (14;20) | 1 (0.3) |
Del (13q14) | 129 (43.6) |
Del (17p13) | 35 (11.8) |
Gain (1q21) | 171 (57.8) |
Cytogenetic abnormality—no. (%) | |
Standard risk | 191 (64.5) |
High-risk | 105 (35.5) |
Missing | 5 |
